Atlas Trials

Transcriptional and Immune Parameters of Response to Belimumab

Clinical trial NCT04570306 · COMPLETED

Trial details

NCT number
NCT04570306
Sponsor
Biomedical Research Foundation, Academy of Athens
Status
COMPLETED
Study type
OBSERVATIONAL
Systemic Lupus Erythematosus
Start date
2020-12-16
Primary completion
2023-12-16
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.